Garlic-derived s-allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Xiao, Jia ^a,b   Guo, Rui ^b   Fung, Man Lung ^b   Liong, Emily C ^b   Chang, Raymond Chuen Chung ^b   Ching, Yick Pang ^b   Tipoe, George L ^b  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYSTEINE DERIVATIVE; GARLIC EXTRACT; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LKB1; PROTEIN P53; S ALLYLMERCAPTOCYSTEINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID DIET; LIPID STORAGE; LIVER; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 84880175454     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/642920     Document Type: Article

References (38)

1. Méndez-Sánchez N., Arrese M., Zamora-Valdés D., Uribe M., Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver International 2007 27 4 423 433 2-s2.0-34047192773 10.1111/j.1478-3231.2007.01483.x (Pubitemid 46534563)
2. Edmilson J., Mccullough A. J., Pathogenesis of non-alcoholic steatohepatitis: human data. Clinical Liver Disease 2007 11 1 75 104 (Pubitemid 46829977)
3. Polyzos S. A., Kountouras J., Zavos C., The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease. Hippokratia 2009 13 2 127 2-s2.0-65749118736
4. Alkhouri N., Carter-Kent C., Feldstein A. E., Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Review of Gastroenterology and Hepatology 2011 5 2 201 212 2-s2.0-79954514102 10.1586/egh.11.6
5. Marzioni M., Glaser S. S., Alpini G., LeSage G. D., Role of apoptosis in development of primary biliary cirrhosis. Digestive and Liver Disease 2001 33 7 531 533 2-s2.0-0034771935 (Pubitemid 32994623)
6. Ramírez M. J., Titos E., Clària J., Navasa M., Fernández J., Rodés J., Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites. Journal of Hepatology 2004 41 1 44 48 2-s2.0-3442878394 10.1016/j.jhep.2004.03.011 (Pubitemid 39005151)
7. Feldstein A. E., Canbay A., Angulo P., Taniai M., Burgart L. J., Lindor K. D., Gores G. J., Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003 125 2 437 443 2-s2.0-0042165989 10.1016/S0016-5085(03)00907-7 (Pubitemid 36929425)
8. Feldstein A. E., Gores G. J., Apoptosis in alcoholic and nonalcoholic steatohepatitis. Frontiers in Bioscience 2005 10 3 3093 3099 2-s2.0-21344458172 (Pubitemid 40910547)
9. Haupt S., Berger M., Goldberg Z., Haupt Y., Apoptosis-the p53 network. Journal of Cell Science 2003 116 20 4077 4085 2-s2.0-0242319666 10.1242/jcs.00739 (Pubitemid 37337082)
10. Amaral J. D., Xavier J. M., Steer C. J., The role of p53 in apoptosis. Discovery Medicine 2010 9 45 145 152
11. Martinou J. C., Youle R. J., Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Developmental Cell 2011 21 1 92 101
12. Kroemer G., Mariño G., Levine B., Autophagy and the integrated stress response. Molecular Cell 2010 40 2 280 293
13. Komatsu M., Liver autophagy: physiology and pathology. The Journal of Biochemistry 2012 152 1 5 15
14. Lawson L. D., Wang Z. J., Pre-hepatic fate of the organosulfur compounds derived from garlic (Allium sativum). Planta Medica 1993 59 7 A688 A689 2-s2.0-0027762678 (Pubitemid 24023268)
15. Howard E. W., Ling M. T., Chee W. C., Hiu W. C., Wang X., Yong C. W., Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer. Clinical Cancer Research 2007 13 6 1847 1856 2-s2.0-34250191113 10.1158/1078-0432.CCR-06-2074 (Pubitemid 46952955)
16. Liang D., Qin Y., Zhao W., Zhai X., Guo Z., Wang R., Tong L., Lin L., Chen H., Wong Y. C., Zhong Z., S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions. Cancer Letters 2011 310 1 69 76 2-s2.0-79961129315 10.1016/j.canlet.2011.06.019
17. 2Kinase 1 activation. Cancer Research 2003 63 20 6825 6837 2-s2.0-0142188703 (Pubitemid 37322965)
18. Sumioka I., Matsura T., Yamada K., Therapeutic effect of S-allylmercaptocysteine on acetaminophen-induced liver injury in mice. European Journal of Pharmacology 2001 433 2-3 177 185 2-s2.0-0035930888 10.1016/S0014-2999(01)01503-5 (Pubitemid 34045178)
19. Xiao J., Liong E. C., Ling M. T., Ching Y. P., Fung M. L., Tipoe G. L., S-allylmercaptocysteine reduces carbon tetrachloride-induced hepatic oxidative stress and necroinflammation via nuclear factor kappa B-dependent pathways in mice. European Journal of Nutrition 2011 51 3 323 333 2-s2.0-79959262606 10.1007/s00394-011-0217-0
20. Xiao J., Ching Y. P., Liong E. C., Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. European Journal of Nutrition 2013 52 1 179 191 10. 1007/s00394-012-0301-0
21. Walsh J. G., Cullen S. P., Sheridan C., Lüthi A. U., Gerner C., Martin S. J., Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 12815 12819 2-s2.0-51349139607 10.1073/pnas.0707715105
22. Centis E., Marzocchi R., Di Domizio S., Ciaravella M. F., Marchesini G., The effect of lifestyle changes in non-alcoholic fatty liver disease. Digestive Diseases 2010 28 1 267 273 2-s2.0-77952574249 10.1159/000282101
23. Rafiq N., Younossi Z. M., Effects of weight loss on nonalcoholic fatty liver disease. Seminars in Liver Disease 2008 28 4 427 433 2-s2.0-56649106415 10.1055/s-0028-1091986
24. Ribeiro P. S., Cortez-Pinto H., Solá S., Castro R. E., Ramalho R. M., Baptista A., Moura M. C., Camilo M. E., Rodrigues C. M. P., Hepatocyte apoptosis, expression of death receptors, and activation of NF- B in the liver of nonalcoholic and alcoholic steatohepatitis patients. American Journal of Gastroenterology 2004 99 9 1708 1717 2-s2.0-4544335155 10.1111/j.1572-0241.2004. 40009.x (Pubitemid 39237497)
25. Feldstein A. E., Canbay A., Guicciardi M. E., Higuchi H., Bronk S. F., Gores G. J., Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. Journal of Hepatology 2003 39 6 978 983 2-s2.0-0348134733 10.1016/S0168-8278(03)00460-4 (Pubitemid 37523769)
26. Farrell G. C., Larter C. Z., Hou J. Y., Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. Journal of Gastroenterology and Hepatology 2009 24 3 443 452
27. Tipoe G. L., Ho C. T., Liong E. C., Leung T. M., Lau T. Y., Fung M. L., Nanji A. A., Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histology and Histopathology 2009 24 9 1161 1169 2-s2.0-70349779693
28. Shirin H., Pinto J. T., Kawabata Y., Soh J. W., Delohery T., Moss S. F., Murty V., Rivlin R. S., Holt P. R., Weinstein I. B., Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Research 2001 61 2 725 731 2-s2.0-0035863512 (Pubitemid 32128639)
29. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A. M., Czaja M. J., Autophagy regulates lipid metabolism. Nature 2009 458 7242 1131 1135 2-s2.0-65949095803 10.1038/nature07976
30. Mei S., Ni H. M., Manley S., Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. Journal of Pharmacology and Experimental Therapeutics 2011 339 2 487 498
31. Chang G. R., Chiu Y. S., Wu Y. Y., Chen W. Y., Liao J. W., Chao T. H., Mao F. C., Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice. Journal of Pharmacological Sciences 2009 109 4 496 503 2-s2.0-66249088672 10.1254/jphs.08215FP
32. Ni H. M., Williams J. A., Yang H., Targeting autophagy for the treatment of liver diseases. Pharmacological Research 2012 66 6 463 474
33. Filomeni G., Cardaci S., Da Costa Ferreira A. M., Rotilio G., Ciriolo M. R., Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: Evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment. Biochemical Journal 2011 437 3 443 453 2-s2.0-79960263592 10.1042/BJ20110510
34. Ix J. H., Sharma K., Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. Journal of the American Society of Nephrology 2010 21 3 406 412 2-s2.0-77949882555 10.1681/ASN.2009080820
35. Kim Y. W., Lee S. M., Shin S. M., Hwang S. J., Brooks J. S., Kang H. E., Lee M. G., Kim S. C., Kim S. G., Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. Free Radical Biology and Medicine 2009 47 7 1082 1092 2-s2.0-69249240216 10.1016/j.freeradbiomed.2009.07.018
36. Sang M. S., Il J. C., Sang G. K., Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 β inhibition downstream of poly(ADP-ribose) polymerase-LKB1 pathway. Molecular Pharmacology 2009 76 4 884 895 2-s2.0-70349324339 10.1124/mol.109.058479
37. Han J. W., Zhan X. R., Li X. Y., Xia B., Wang Y. Y., Zhang J., Li B. X., Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats. World Journal of Gastroenterology 2010 16 48 6111 6118 2-s2.0-78650772804 10.3748/wjg.v16.i48.6111
38. Singh R., Cuervo A. M., Lipophagy: connecting autophagy and lipid metabolism. International Journal of Cell Biology 2012 2012 12 282041 10. 1155/2012/282041